Related Experiment Videos
Angioimmunoblastic lymphadenopathy after infectious mononucleosis
British Medical Journal (Clinical Research Ed.)
|May 16, 1981
Summary
A severe case of angioimmunoblastic lymphadenopathy developed in a man 16 months after Epstein-Barr virus (EBV) infectious mononucleosis. This aggressive condition, potentially linked to EBV and measles infections, proved fatal despite extensive treatment.
Area of Science:
- Immunology
- Virology
- Oncology
Background:
- Infectious mononucleosis, often caused by Epstein-Barr virus (EBV), can have prolonged and severe presentations.
- Angioimmunoblastic lymphadenopathy (AILD) is a rare T-cell lymphoma with a complex etiology.
- The interplay between viral infections and immune dysregulation is crucial in lymphomagenesis.
Observation:
- A 46-year-old man experienced severe infectious mononucleosis due to EBV, complicated by an asymptomatic measles virus infection.
- Sixteen months post-mononucleosis, he developed massive lymphadenopathy, diagnosed as angioimmunoblastic lymphadenopathy via biopsy.
- Clinical presentation included fever, pharyngitis, lymphadenopathy, hepatosplenomegaly, and specific EBV antibodies.
Findings:
- Biopsy revealed diffuse lymphoid infiltration and characteristic arborizing small vessel proliferation of AILD.
- The patient's condition was refractory to multiple treatments including corticosteroids, levamisole, chlorambucil, and radiotherapy.
- Death occurred 18 months after disease onset due to secondary infections.
Implications:
- This case highlights a potential association between prior EBV and measles virus infections and the subsequent development of AILD.
- It underscores the complex immunological changes that may precipitate lymphoproliferative disorders.
- Further research into viral triggers and immune responses in AILD pathogenesis is warranted.